Recurrence After Stopping Maintenance Electroconvulsive Therapy: A Retrospective Case Series.


Journal

The journal of ECT
ISSN: 1533-4112
Titre abrégé: J ECT
Pays: United States
ID NLM: 9808943

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 20 6 2020
medline: 5 10 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

Relapses and recurrence remain the greatest risks posed by patients with severe mood disorders after discontinuation of electroconvulsive therapy (ECT). To date, despite a wide range of literature on ECT, little is known about the rate of recurrence of depression after maintenance ECT (mECT) discontinuation specifically. This study sought to address this lacuna, confronting literature data to the results of a retrospective case study. A comprehensive review was conducted, followed by a retrospective analysis of 18 cases of mECT discontinuation between January 2011 and June 2016 involving patients with affective disorders. The comprehensive review revealed that only 3 studies have assessed recurrence rate after c/mECT discontinuation. In our retrospective analysis, mean (SD) mECT duration was 12.69 (12.16) months. A new mood event (usually a depressive state) was observed in 50% of the cases, and 44% of those recurrences occurred during the first 6 months after discontinuation. Given that high recurrence rates are observed after mECT discontinuation, the authors discuss the advantages of long-term mECT and the choice of concomitant pharmacotherapy for severe and complex affective disorders.

Identifiants

pubmed: 32558761
doi: 10.1097/YCT.0000000000000693
pii: 00124509-202012000-00009
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-271

Références

Fink M. Convulsive therapy: a review of the first 55 years. J Affect Disord. 2001;63:1–15.
UK ECT Review Group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799–808.
Kellner CH. Relapse after electroconvulsive therapy (ECT). J ECT. 2013;29:1–2.
American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging. 2nd ed. Washington, DC: American Psychiatric Press; 2001.
Petrides G, Tobias KG, Kellner CH, et al. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology. 2011;64:129–140.
Nordenskjöld A, von Knorring L, Engström I. Rehospitalization rate after continued electroconvulsive therapy—a retrospective chart review of patients with severe depression. Nord J Psychiatry. 2011;65:26–31.
Brown ED, Lee H, Scott D, et al. Efficacy of continuation/maintenance electroconvulsive therapy for the prevention of recurrence of a major depressive episode in adults with unipolar depression: a systematic review. J ECT. 2014;30:195–202.
Shelef A, Mazeh D, Berger U, et al. Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness. J ECT. 2015;31:125–128.
Post T, Kemmler G, Krassnig T, et al. Efficacy of continuation and maintenance electroconvulsive therapy (c/m ECT) in the treatment of patients with therapy-resistant affective disorders: a retrospective analysis. Neuropsychiatry. 2015;29:133–138.
Cosculluela A, Cobo J, Martínez-Amorós E, et al. Effectivity and cost-effectivity of the maintenance electroconvulsive therapy: a mirror naturalistic analysis. Actas Esp Psiquiatr. 2017;45:257–267.
Hausmann A, Post T, Post F, et al. Efficacy of continuation/maintenance electroconvulsive therapy in the treatment of patients with mood disorders: a retrospective analysis. J ECT. 2019;35:122–126.
Sieneart P, Peuskens J. Electroconvulsive therapy: an effective therapy of medication-resistant bipolar disorder. Bipolar Disord. 2006;8:304–306.
Santos Pina L, Bouckaert F, Obbels J, et al. Maintenance electroconvulsive therapy in severe bipolar disorder: a retrospective chart review. J ECT. 2016;32:23–28.
O'Connor DW, Gardner B, Presnell I. The effectiveness of continuation-maintenance ECT in reducing depressed older patients' hospital re-admissions. J Affect Disord. 2010;120:62–66.
van Schaik AM, Comijs HC, Sonnenberg CM, et al. Efficacy and safety of continuation and maintenance electroconvulsive therapy in depressed elderly patients: a systematic review. Am J Geriatr Psychiatry. 2012;20:5–17.
Rapinesi C, Kotzalidis GD, Serata D, et al. Prevention of relapse with maintenance electroconvulsive therapy in elderly patients with major depressive episode. J ECT. 2013;29:61–64.
Sutor B, Rasmussen KG. Clinical challenges in maintenance electroconvulsive therapy for older patients with medical comorbidity. J ECT. 2016;32:67–69.
Agence Nationale de l'Accréditation et de l'Evaluation en Santé. Indications et modalités de l'électroconvulsivothérapie. Paris: ANAES; 1997.
Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63:1337–1344.
Jelovac A, Kolshus E, McLoughlin DM. Relapse following successful electroconvulsive therapy for major depression: a meta-analysis. Neuropsychopharmacology. 2013;38:2467–2474.
Milev RV, Giacobbe P, Kennedy SH, et al., CANMAT Depression Work Group. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 4. Neurostimulation treatments. Can J Psychiatry. 2016;61:561–575.
Lisanby SH, Sampson S, Husain MM, et al. Toward individualized post-electroconvulsive therapy care: piloting the symptom-titrated, algorithm-based longitudinal ECT (STABLE) intervention. J ECT. 2008;24:179–182.
Trevino K, Mcclintock SM, Husain MM. A review of continuation electroconvulsive therapy: application, safety and efficacy. J ECT. 2010;26:186–195.
Rabheru K. Maintenance electroconvulsive therapy (m-ECT) after acute response examining the evidence for who, what, when, and how? J ECT. 2012;28:39–47.
National Institute for Clinical Excellence. Guidance on the Use of Electroconvulsive Therapy: Update 2010. London: National Institute for Clinical Excellence; 2014.
Fox HA. Continuation and maintenance electroconvulsive therapy—a conceptual framework? J ECT. 2015;31:e27–e28.
Gill SP, Kellner CH. Clinical practice recommendations for continuation and maintenance electroconvulsive therapy for depression: outcomes from a review of the evidence and a consensus workshop held in Australia in May 2017. J ECT. 2019;35:14–20.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Gupta S, Tobiansky R, Bassett P, et al. Efficacy of maintenance electroconvulsive therapy in recurrent depression: a naturalistic study. J ECT. 2008;24:191–194.
Odeberg H, Rodriguez-Silva B, Salander P, et al. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study. J ECT. 2008;24:183–190.
Huuhka K, Viikki M, Tammentie T, et al. One-year follow-up after discontinuing maintenance electroconvulsive therapy. J ECT. 2012;28:225–228.
Josse J, Husson F. Handling missing values in exploratory multivariate data analysis methods. J Soc Fr Stat. 2012;153:79–99.
Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA. 2001;285:1299–1307.
Prudic J, Haskett RF, McCall WV, et al. Pharmacological strategies in the prevention of relapse after electroconvulsive therapy. J ECT. 2013;29:3–12.
Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163:1905–1917.
Heijnen WT, Birkenhager TK, Wierdsma AI, et al. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol. 2010;30:616–619.
Elias A, Chathanchirayil SJ, Bhat R, et al. Maintenance electroconvulsive therapy up to 12 years. J Affect Disord. 2014;156:228–231.
Kellner CH, Husain MM, Knapp RG, et al. A novel strategy for continuation ECT in geriatric depression: phase 2 of the PRIDE study. Am J Psychiatry. 2016;173:1110–1118.
McCall WV, Lisanby SH, Rosenquist PB, et al. Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: a randomized clinical trial. J Psychiatr Res. 2018;97:65–69.
Russell JC, Rasmussen KG, O'Connor MK, et al. Long-term maintenance ECT: a retrospective review of efficacy and cognitive outcome. J ECT. 2003;19:4–9.
Kirov GG, Owen L, Ballard H, et al. Evaluation of cumulative cognitive deficits from electroconvulsive therapy. Br J Psychiatry. 2016;208:266–270.
Diniz BS, Machado-Vieira R, Forlenza OV. Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat. 2013;9:493–500.
Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci. 2014;5:443–450.

Auteurs

Clémence Cabelguen (C)

From the Addictology and Liaison Psychiatry Department, University Hospital of Nantes.

Pascal Caillet (P)

Center of Evaluation and Information on Drug Dependence, Department of Clinical Pharmacology, Institute of Biology, Nantes.

David Szekely (D)

Department of Psychiatry, Princess Grace Hospital, Principality of Monaco.

Anne Pichot (A)

From the Addictology and Liaison Psychiatry Department, University Hospital of Nantes.

Jean-Marie Vanelle (JM)

From the Addictology and Liaison Psychiatry Department, University Hospital of Nantes.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH